Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/1998
10/27/1998US5827887 Biphenyl compounds
10/27/1998US5827883 Topical drug delivery; side effect reduction
10/27/1998US5827869 Substituted biphenyl isoxazole sulfonamides
10/27/1998US5827850 1,2,4-benzotriazine oxides formulations
10/27/1998US5827849 Cyclic dericatives, pharmaceutical compositions containing these compounds and processes for preparing them
10/27/1998US5827846 Carbazole derivatives as agents against multi-drug resistance
10/27/1998US5827834 Method of using hyaluronic acid or its pharmaceutically acceptable salts for the treatment of disease
10/27/1998US5827831 Lipid nucleotide analog prodrugs for oral administration
10/27/1998US5827703 Methods and composition for in vivo gene therapy
10/27/1998US5827691 Process for preparing a protein which inhibits metastasis of cancer
10/27/1998US5827666 Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof
10/27/1998CA2063721C Mycobacterium chelonae polar glycopeptidolipids-based immune booster medication
10/27/1998CA1340107C Linear and cyclic analoques of alpha-msh fragments with extraordinary potency
10/25/1998CA2207753A1 Modulators of multi-drug resistances
10/24/1998CA2228743A1 Novel integrin ligand itgl-tsp
10/22/1998WO1998046769A1 Composition and method for inducing an immune response against tumour-related antigens
10/22/1998WO1998046760A1 A gene delivery vehicle expressing the apoptosis-inducing proteins vp2 and/or apoptin
10/22/1998WO1998046758A1 Human tumor-associated kazal inhibitor
10/22/1998WO1998046731A1 Inhibitors for urokinase receptor
10/22/1998WO1998046648A1 Interactive system for substance presentation and elimination
10/22/1998WO1998046645A2 Method for the production of antihuman antigen receptors and uses thereof
10/22/1998WO1998046642A1 MODIFIED TNFα MOLECULES, DNA ENCODING SUCH MODIFIED TNFα MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFα MOLECULES AND DNA
10/22/1998WO1998046638A1 A novel th2-specific gene
10/22/1998WO1998046635A1 GnRH ANTAGONISTS
10/22/1998WO1998046634A1 GnRH ANTAGONISTS BEING MODIFIED IN POSITIONS 5 AND 6
10/22/1998WO1998046632A2 Inhibitors for urokinase receptor
10/22/1998WO1998046602A1 Alkaloid halide salts of swainsonine and methods of use
10/22/1998WO1998046598A1 Anti-cancer drug aldehyde conjugate drugs with enhanced cytotoxicity: compounds, compositions and methods
10/22/1998WO1998046575A1 Crambescidin compounds
10/22/1998WO1998046563A1 Metalloproteinase inhibitors
10/22/1998WO1998046276A1 Chelating agents
10/22/1998WO1998046270A2 Polymeric conjugates polyvalently presenting an agent for therapy
10/22/1998WO1998046252A1 Therapeutic, prophylactic and diagnostic agent for cancer, useful for characterising cancer cells with individual properties
10/22/1998WO1998046246A1 α-O-LINKED GLYCOCONJUGATES WITH CLUSTERED (2,6)-ST EPITOPES, METHODS OF PREPARATION AND USES THEREOF
10/22/1998WO1998046222A1 Pharmaceutical compositions for immunosuppression, anticancer and antiviral treatment
10/22/1998WO1998046218A1 Phorbol esters as anti-neoplastic agents
10/22/1998WO1998046080A1 Nucleophile substituted ecteinascidins and n-oxide ecteinascidins
10/22/1998WO1998046076A1 Retinoid related molecules for the inhibition of endothelin-1 overproduction in disease
10/22/1998WO1998036068A3 Human p24 vesicle proteins
10/22/1998WO1998035028A3 An oncolytic/immunogenic complementary-adenoviral vector system
10/22/1998WO1998032463A3 Lyophilizate of lipid complex of water insoluble porphyrins
10/22/1998WO1998031399A3 Labelled factor xiiia substrates
10/22/1998WO1998002190A3 Cationic amphiphile/dna complexes
10/22/1998DE19745792C1 Isolation of wound healing regulatory factors
10/22/1998CA2289476A1 Modified tnf.alpha. molecules, dna encoding such modified tnf.alpha. molecules and vaccines comprising such modified tnf.alpha. molecules and dna
10/22/1998CA2287779A1 Human tumor-associated kazal inhibitor
10/22/1998CA2287518A1 A novel th2-specific gene
10/22/1998CA2286798A1 Alpha-o-linked glycoconjugates with clustered(2,6)-st epitopes, methods of preparation and uses thereof
10/22/1998CA2286790A1 Chelating agents
10/22/1998CA2286738A1 Crambescidin compounds
10/22/1998CA2286692A1 Polymeric conjugates polyvalently presenting an agent for therapy
10/22/1998CA2286557A1 Phorbol esters as anti-neoplastic agents
10/22/1998CA2286477A1 Composition and method for inducing an immune response against tumour-related antigens
10/22/1998CA2286332A1 Inhibitors for urokinase receptor
10/22/1998CA2286181A1 Anti-cancer drug aldehyde conjugate drugs with enhanced cytotoxicity: compounds, compositions and methods
10/22/1998CA2234399A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor
10/22/1998CA2231740A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor
10/21/1998EP0872478A2 Intermediates for the preparation of 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
10/21/1998EP0871883A1 Compounds and methods related to parathyroid hormone-like protein
10/21/1998EP0871757A1 Conditionally replicating viral vectors and their use
10/21/1998EP0871756A2 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
10/21/1998EP0871755A1 Vectors for gene delivery
10/21/1998EP0871748A2 Delivery of biologically active polypeptides
10/21/1998EP0871702A1 Cytokine designated lerk-7
10/21/1998EP0871673A1 Bispecific antibodies in which the binding capability is reversibly inhibited by a photocleavable moiety
10/21/1998EP0871672A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
10/21/1998EP0871666A1 Receptor-selective somatostatin analogs
10/21/1998EP0871663A2 New form of amphiregulin, methods for producing and using the same and compositions comprising the same
10/21/1998EP0871661A1 Novel protein domain which binds tyrosine phosphorylated proteins
10/21/1998EP0871656A1 Novel dolastatin derivatives, their preparation and use
10/21/1998EP0871655A2 Pcna binding substance
10/21/1998EP0871645A1 Modulators of the function of fas/apo1 receptors
10/21/1998EP0871624A1 Antagonists of gonadotropin releasing hormone
10/21/1998EP0871623A1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
10/21/1998EP0871496A1 Arteriovenous and venous graft treatments: methods and compositions
10/21/1998EP0871494A1 Compositions and methods for treating tumor cells
10/21/1998EP0871492A2 Mesothelium antigen and methods and kits for targeting it
10/21/1998EP0871490A1 Branched hydrazone linkers
10/21/1998EP0871487A1 Dendritic cell stimulatory factor
10/21/1998EP0871481A1 Pseudomonas exotoxin as immunogenic carrier in synthetic conjugate vaccines
10/21/1998EP0871475A2 Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors
10/21/1998EP0871470A1 Haemopoietic growth factor antagonists and uses therefor
10/21/1998EP0871467A1 Novel formulation for peptide release
10/21/1998EP0871452A2 Sulfate conjugates of ursodeoxycholic acid, and their beneficial use in inflammatory disorders and other applications
10/21/1998EP0871448A1 Aryl and heteroaryl quinazoline compounds which inhibit csf-1r receptor tyrosine kinase
10/21/1998EP0871447A1 Water soluble camptothecin analogs
10/21/1998EP0871437A1 Use of boswellic acid for treating brain tumours
10/21/1998EP0871432A2 Biological agent compositions
10/21/1998EP0790769A4 Eleutherobin and analogs thereof
10/21/1998EP0789568A4 Antineoplastic cocoa extracts, methods for making, using
10/21/1998EP0738327B1 Host-vector system for use in gene therapy
10/21/1998EP0710227B1 Vitamin d analogues
10/21/1998EP0651740B1 Amino acid linked nitrogen mustard derivatives and their use as prodrugs in the treatment of tumours
10/21/1998CN1196731A Diglycosylated 1,2-diols as mimetics of sialyl-lewis X and sialyl-Lewis A analogies
10/21/1998CN1196724A Piperazine devivatives and process for preparation thereof
10/21/1998CN1196720A Novel vitamin D analogues
10/21/1998CN1196678A Di-and trivalent small molecule selecting protein inhibitors
10/21/1998CN1196263A Traditional Chinese medicine preparation for treating leukocythemia
10/21/1998CN1196253A Medicine for treating gastric cancer and preparation method thereof
10/20/1998US5824805 Branched hydrazone linkers
1 ... 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 ... 2211